TP53 and triple-negative breast carcinoma: In conclusion, our study indicated that ziyuglycoside I inhibited the proliferation of triple-negative breast cancer MDA-MB-231 cells by inducing p53-mediated G2/M arrest and intrinsic/extrinsic apoptotic pathways (Figure 10).